Pfizer’s Future in Cell and Gene Therapy - 2021 World Medical Innovation Forum
May 2–4, 2022

Pfizer’s Future in Cell and Gene Therapy

Pfizer’s Future in Cell and Gene Therapy

Wednesday, May 19, 2021

5:00 PM – 5:20 PM

Currently playing a critical role in delivering hope for a post-pandemic future, Pfizer is making cell and gene therapies important components in its drug development portfolio. This conversation will explore the development of the Pfizer/BioNTech COVID-19 vaccine and scientific opportunity for mRNA, Pfizer’s efforts in gene therapy for some rare diseases, the role of partnerships and collaborations in the Pfizer strategy, and how the company plans to address manufacturing and bioprocessing needs as CGT products emerge.

Jonathan Kraft
  • President, The Kraft Group
  • Chairman of the Board of Trustees, MGH
Daniel Haber, MD, PhD
  • Chair, Cancer Center, MGH
  • Isselbacher Professor of Oncology, HMS
Mikael Dolsten, MD, PhD
  • Chief Scientific Officer and President, Worldwide Research, Development and Medical, Pfizer
  • Q&A

    05:25 PM – 05:40 AM

the Future of Medicine and AI

May 11–13, 2020 | Boston, MA